Spire Wealth Management’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-400
| Closed | -$13.4K | – | 2284 |
|
|
2026
Q1 | $13.4K | Hold |
400
| – | – | ﹤0.01% | 1540 |
|
|
2025
Q4 | $13.9K | Hold |
400
| – | – | ﹤0.01% | 1612 |
|
|
2025
Q3 | $14.9K | Hold |
400
| – | – | ﹤0.01% | 1621 |
|
|
2025
Q2 | $13K | Hold |
400
| – | – | ﹤0.01% | 1641 |
|
|
2025
Q1 | $10.8K | Buy |
400
+200
| +100% | +$5.87K | ﹤0.01% | 1813 |
|
|
2024
Q4 | $5.72K | Hold |
200
| – | – | ﹤0.01% | 2008 |
|
|
2024
Q3 | $5.38K | Hold |
200
| – | – | ﹤0.01% | 1800 |
|
|
2024
Q2 | $5.55K | Buy |
200
+100
| +100% | +$2.73K | ﹤0.01% | 1804 |
|
|
2024
Q1 | $2.76K | Hold |
100
| – | – | ﹤0.01% | 2036 |
|
|
2023
Q4 | $2.46K | Hold |
100
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q3 | $2.24K | Hold |
100
| – | – | ﹤0.01% | 2113 |
|
|
2023
Q2 | $2.56K | Hold |
100
| – | – | ﹤0.01% | 2152 |
|
|
2023
Q1 | $2.36K | Hold |
100
| – | – | ﹤0.01% | 2232 |
|
|
2022
Q4 | $2K | Sell |
100
-500
| -83% | -$12.3K | ﹤0.01% | 2039 |
|
|
2022
Q3 | $15K | Hold |
600
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q2 | $16K | Hold |
600
| – | – | ﹤0.01% | 1748 |
|
|
2022
Q1 | $23K | Sell |
600
-1,200
| -67% | -$46.6K | ﹤0.01% | 1751 |
|
|
2021
Q4 | $83K | Hold |
1,800
| – | – | ﹤0.01% | 1489 |
|
|
2021
Q3 | $85K | Sell |
1,800
-141
| -7% | -$6.59K | ﹤0.01% | 1249 |
|
|
2021
Q2 | $90K | Hold |
1,941
| – | – | ﹤0.01% | 1215 |
|
|
2021
Q1 | $85K | Buy |
+1,941
| New | +$88.1K | ﹤0.01% | 1462 |
|
Other funds holding FFTY
Spire Wealth Management's FFTY Position: Q2 2026 in Review
Spire Wealth Management sold out of CapForce IBD 50 ETF (FFTY) in Q2 2026, closing a stake of 400 shares — an estimated $13.4K sold.
Spire Wealth Management first reported a position in FFTY in Q1 2021 and held it in 21 quarters. The position peaked at $90K in Q2 2021. 2 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.
- Spire Wealth Management reported no remaining CapForce IBD 50 ETF position as of Q2 2026 after selling out during the quarter.
- Spire Wealth Management sold 400 CapForce IBD 50 ETF shares in Q2 2026, an estimated $13.4K.
- Spire Wealth Management first reported a position in CapForce IBD 50 ETF in Q1 2021 and held it in 21 quarters.
- Spire Wealth Management's CapForce IBD 50 ETF position peaked at $90K in Q2 2021.
- 2 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.